Cetuximab-dependent ADCC in cancer: dream or reality?

Cancer Immunol Immunother. 2010 Oct;59(10):1607-8; author reply 1609-10. doi: 10.1007/s00262-010-0884-3. Epub 2010 Jun 25.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antibody-Dependent Cell Cytotoxicity*
  • Antineoplastic Agents / therapeutic use*
  • Cetuximab
  • Humans
  • Neoplasms / drug therapy*
  • Neoplasms / immunology

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Cetuximab